Alligent Biopharm Consulting - Ownership and Business Overview

Business ServicesCompany

Alligent Biopharm Consulting Ownership

Who owns Alligent Biopharm Consulting?

Alligent Biopharm Consulting is owned by Envision Pharma. It was acquired on September 9, 2015.

Alligent Biopharm Consulting Business Overview

Where is Alligent Biopharm Consulting headquartered?

Alligent Biopharm Consulting is headquartered in Stirling, New Jersey.

What sector is Alligent Biopharm Consulting in?

Alligent Biopharm Consulting is a business services company.

Business Services M&A Summary in 2015

Out of 60 sectors in the Mergr database, business services ranked 4 in number of deals in 2015. The largest business services acquisition in 2015 was ITR Concession - which was acquired by IFM Investors Private Equity for $5.7B.

Join Mergr to view all 634 acquisitions of business services companies in 2015, including 95 acquisitions by private equity firms, and 539 by strategics.

Alligent Biopharm Consulting LLC

331 Elm Street,
Stirling, New Jersey 07980
United States,
(908) 604-0647
www.alligentgroup.com

Alligent Biopharm Consulting LLC is a medical affairs agency that develops and delivers strategically-focused, integrated, and aligned medical communications solutions to the biopharma industry. Alligent Biopharm Consulting is based in Stirling, New Jersey.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.